Drug Profile
Mucoadhesive metronidazole benzoate
Alternative Names: Metronidazole benzoateLatest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator Tillotts Pharma
- Class Antibacterials; Antiprotozoals; Nitroimidazoles; Radiosensitisers; Skin disorder therapies; Small molecules
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Gastrointestinal motility disorders
Most Recent Events
- 28 Nov 2019 No recent reports of development identified for phase-I development in Gastrointestinal motility disorders(In volunteers) in Switzerland (PO, Tablet)
- 06 Mar 2017 Tillotts Pharma completes a phase I trial in Gastrointestinal motility disorders (In volunteers) in Switzerland (PO) (NCT02911298)
- 01 Oct 2016 Phase-I clinical trials in Gastrointestinal motility disorders (In volunteers) in Switzerland (PO) (NCT02911298)